TURNOVER (x1000 DKK)
NET PROFIT (x1000 DKK)
EMPLOYEES
RexCell Tissue & Airlaid AB
Closing information (x1000 DKK)
| Closing information | 2024/12 | 2023/12 | 2022/12 |
| Turnover |
849,540
|
980,230
|
872,241 |
| Financial expenses |
522
|
555
|
335 |
| Earnings before taxes |
192,122
|
282,302
|
159,358 |
| EBITDA |
200,699
|
293,215
|
178,722 |
| Total assets |
401,796
|
404,029
|
448,336 |
| Current assets |
204,661
|
218,789
|
267,540 |
| Current liabilities |
156,834
|
151,646
|
190,015 |
| Equity capital |
203,808
|
209,646
|
214,842 |
| - share capital |
779
|
806
|
802 |
| Employees (average) |
196
|
200
|
194 |
Financial ratios
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Solvency |
50.7%
|
51.9%
|
47.9% |
| Turnover per employee |
4,334
|
4,901
|
4,496 |
| Profit as a percentage of turnover |
22.6%
|
28.8%
|
18.3% |
| Return on assets (ROA) |
47.9%
|
70.0%
|
35.6% |
| Current ratio |
130.5%
|
144.3%
|
140.8% |
| Return on equity (ROE) |
94.3%
|
134.7%
|
74.2% |
| Change turnover |
-98,268
|
103,498
|
313,741 |
| Change turnover % |
-10%
|
12%
|
56% |
| Chg. No. of employees |
-4
|
6
|
4 |
| Chg. No. of employees % |
-2%
|
3%
|
2% |
Total value of public sale
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.